We thus assessed RANK expression on NK cells of the cancer patients and HD as well as the NK cell line NK92 and ex vivo preactivated polyclonal NK (pNK) cells that are presently evaluated for cancer treatment [21,22,23]. The gene discussed is TNFRSF11A; the disease is cancer.